戻る Agenda
Outcomes Measurement: The Key to Value-Based Healthcare
Session Chair(s)
Wim Goettsch, PHD, MSC
Special Advisor HTA
Dutch National Health Care Institute (ZIN), Netherlands
The concept of Value Based Health Care (VBHC) is becoming a leading principle in hospitals to guide quality of care. In order to establish VHBC quality of care is measured with patient relevant outcomes using ICHOM (International Consortium for Health Outcomes Measurement) criteria. During this session we will introduce VBHC and the ICHOM outcomes but also discuss an example of breast cancer care for which VBHC and ICHOM have been used. Subsequently, different stakeholders such as industry, HTA, regulators and patients discuss to which extent VBHC and ICHOM could be relevant for the development of new drugs, for instance in breast cancer, and their value assessment by regulators and HTA.
Speaker(s)
Panelist
Annemarie Haverhals, MSC
Independent Consultant On VBHC, Netherlands
Panelist
Adam Heathfield, PHD
Pfizer Inc, United Kingdom
Senior Director, Global Access and Value
Panelist
Niklas Hedberg, MPHARM
Dental and Pharmaceutical Benefits Agency, TLV, Sweden
HTACG Co-Chair & Chief Pharmacist
Panel Discussion
Hubert Leufkens, PHARMD, PHD
Utrecht University, Netherlands
Emeritus Professor of Pharmaceutical Policy and Regulatory Science